SCHEMBL29472215

SCHEMBL29472215

O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2cccc(N=C=S)c21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 10/20 0.55
MAPT P10636 3/20 0.55
HPGD P15428 2/20 0.55
MEN1 O00255 2/20 0.55
HTT P42858 2/20 0.55
KMT2A Q03164 2/20 0.55
CYP2C19 P33261 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
SMAD3 P84022 1/20 0.55
PRMT1 Q99873 1/20 0.55
ACE2 Q9BYF1 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
ALDH1A1 P00352 2/20 0.53
ALOX12 P18054 2/20 0.53
CYP2C9 P11712 1/20 0.53
ALOX15 P16050 1/20 0.53
BRCA1 P38398 1/20 0.53
HSD17B10 Q99714 1/20 0.53
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16544 1.00 FTO (0.55) FTOMAPTHPGDMEN1HTT
Hydrochloric Acid SCHEMBL5440613 0.99 FTO (0.54) FTOMAPTHPGDMEN1HTT
SCHEMBL9013831 0.99 FTO (0.54) FTOMAPTHPGDMEN1HTT
SCHEMBL10486825 0.99 FTO (0.54) FTOMAPTHPGDMEN1HTT
Ethylenediamine SCHEMBL17865717 0.95 FTO (0.50) FTOMAPTHPGDMEN1HTT
Hexaethylene Glycol SCHEMBL5438588 0.90 FTO (0.46) FTOMAPTHPGDMEN1HTT
SCHEMBL136169 0.89 FTO (0.56) FTOMAPTHPGDMEN1HTT
SCHEMBL5664537 0.87 FTO (0.51) FTOMAPTHPGDMEN1HTT
SCHEMBL3484938 0.87 FTO (0.43) FTOMAPTHPGDMEN1HTT
SCHEMBL11220390 0.86 FTO (0.50) FTOMAPTHPGDMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4590341-A1 POLYMERS WITH DUAL THERAPEUTIC AGENTS Sony Group Corporation (JP) 2025-07-30 EP disclosed
EP-4590340-A1 POLYMERS WITH STEROIDS OR VITAMINS Sony Group Corporation (JP) 2025-07-30 EP disclosed
WO-2024062319-A1 POLYMERS WITH DUAL THERAPEUTIC AGENTS Sony Group Corporation (JP) 2024-03-28 WO disclosed
WO-2024062318-A1 POLYMERS WITH STEROIDS OR VITAMINS Sony Group Corporation (JP) 2024-03-28 WO disclosed
EP-3497215-B1 CELL-PERMEABLE (CP)-CAS9 RECOMBINANT PROTEIN AND USES THEREOF CELLIVERY THERAPEUTICS INC (KR) 2024-01-10 EP disclosed
EP-3341395-B1 IMPROVED CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF CELLIVERY THERAPEUTICS INC (KR) 2023-11-29 EP disclosed
CN-112378891-B Reagent and method for detecting concentration and content of meropenem in mixed solution 宁波大学 2022-03-22 CN disclosed